weight loss

Doctors are warning that people taking GLP-1 weight-loss and diabetes drugs such as Ozempic face heightened health risks during the current heat wave. The drugs can contribute to dehydration, and patients may not feel thirsty or may experience nausea and vomiting, making it harder to stay hydrated. Medical experts are advising users to drink water regularly, avoid excessive heat, and seek medical attention if they develop dizziness or other symptoms of dehydration.

Physician Sean O'Mara joined Megyn Kelly's show to discuss nutrition advice attracting wide attention. He promoted what he calls the 'living diet,' explained why visceral fat around internal organs is especially dangerous to health, and argued that fermented foods offer significant value. The conversation drew a large audience, with viewers reacting to his claims about diet and weight loss.

Patients taking Ozempic and similar GLP-1 weight-loss and diabetes drugs are reporting nail problems, adding to earlier complaints of hair loss. The reports have surfaced as use of the medications surges worldwide, and users are swapping accounts of brittle, damaged or abnormal nails. It remains unclear whether the drugs directly cause the nail changes or whether rapid weight loss and nutritional shifts are responsible, and regulators have not established a confirmed link.

Researchers report that three days of fasting triggers systemic changes across the body, according to findings covered by ScienceDaily and picked up by news outlets. The study suggests the effects extend well beyond weight loss, with broad physiological shifts emerging only after the 72-hour mark. The findings are prompting discussion about what prolonged fasting actually does to human health.

Mexico's national team lost to the United States, a result drawing wide attention across Mexico, Spain and the US. ESPN México reports that coach Jaime Lozano-era analyst Márquez's project remains unaffected by the defeat, arguing the loss does not undermine the team's longer-term development plan despite the rivalry's emotional weight for fans.

GLP-1 drugs like Ozempic and Wegovy are changing shopping habits, and retailers are taking notice. Users report reduced appetite and smaller grocery baskets, prompting stores and food companies to reassess portions, product mixes, and marketing. Industry analysts say the shift could reshape demand across food, snack, and apparel categories as adoption of the weight-loss drugs keeps growing.

Pakistani nutritionist Ayesha Nasir has released a diet plan aimed at helping people lose weight during October. The plan is drawing significant attention online, with over 150,000 people engaging with it. Viewers are discussing the diet's promises of effective weight loss and whether the approach is sustainable or realistic for long-term health.

A 30-day October weight loss challenge is drawing attention online, claiming participants can lose up to 13 kilograms in a month through a diet plan built on the idea of 'eat more, lose more'. The plan's rapid-loss promise is prompting interest from people looking for quick results ahead of the festive season.

Ilant Health, an obesity-focused startup, is tying its revenue to improved patient outcomes rather than traditional fee-for-service billing. According to Forbes coverage, the company bets it can succeed financially only if patients actually get healthier, an outcomes-based model still rare in obesity care. The approach highlights a broader push in healthcare to reward results over volume, as demand for weight-loss treatment keeps growing.

Researchers have published new findings on how a full week of fasting affects the human body, detailing the physical changes that occur over seven days without food. The study has drawn wide attention, as interest in extended fasting for weight loss and health keeps growing, and readers are weighing the reported effects against the risks of going without food for so long.

GIANT, the US grocery retailer, is expanding its nutrition and pharmacy services for customers using GLP-1 weight-loss and diabetes medications. The move adds dietitian guidance and pharmacy support to help shoppers manage the dietary changes these drugs often require. It reflects how retailers are racing to serve the fast-growing population of GLP-1 patients.

New research suggests fat cells can retain a 'memory' of obesity, which may help explain why losing weight and keeping it off is so difficult. According to the reporting, adipose cells appear to carry epigenetic changes established during weight gain, altering how they function even after weight loss. The findings are drawing attention in science and health circles, with discussion focused on what this means for obesity treatment and the biology of yo-yo dieting.

Trenton-area columnist Jeff Edlestein reflects on what a home means once the people and moments that filled it are gone, arguing that a house still holds meaning as a keeper of memories even after its residents have moved on or passed away. The piece is a sentimental, personal essay rather than a market story, touching on family, loss and the emotional weight of real estate.

Physical therapist Kylie Balis says she lost 7kg by dropping four common fitness habits, while keeping her strength. She outlines the changes in Women's Health, positioning them as practical adjustments rather than extreme measures. The piece is drawing attention as a relatable, expert-backed take on sustainable weight loss and long-term training habits.

Dr Sean O'Mara, a physician and attorney focused on health and performance, has published what he calls the only carnivore diet guide you will ever need, laying out the all-meat eating approach in full. The guide has drawn over 130,000 likes as interest in meat-only diets for weight loss and performance continues to grow, alongside ongoing debate among nutrition experts about the diet's safety and long-term effects.

Prevention reports on a common fitness question: whether older adults should lift light or heavy weights to maintain muscle as they age. Experts weigh in on which approach best preserves strength and combats age-related muscle loss, offering guidance on safe and effective training for older bodies.

A new study suggests children taking GLP-1 weight-loss and diabetes drugs may be at risk of nutritional deficiencies. The findings raise concerns about how appetite suppression and reduced food intake from medications like Ozempic and Wegovy could affect growing bodies, adding to the ongoing debate over the safety of prescribing these drugs to young patients.

EatingWell has published a roundup of 15 easy high-fiber breakfast ideas aimed at supporting weight loss. The list highlights simple morning meals built around fiber-rich foods, which help keep people fuller for longer. It is part of ongoing seasonal interest in practical diet tips, with readers looking for quick, healthy breakfast options that fit busy routines and weight-management goals.

Giant Co., the US grocery retailer, is broadening its well-being services tailored to customers using GLP-1 weight-loss medications. The expanded offerings are aimed at supporting shoppers on drugs like Ozempic and Wegovy with nutrition guidance and related in-store and pharmacy resources. The move reflects how grocers are racing to serve the fast-growing population of Americans taking GLP-1 treatments.

Danone has developed a new drink targeting consumers taking weight loss medications such as GLP-1 drugs, according to a report carried by Polish Radio. The product is aimed at people whose reduced appetite on these treatments creates demand for nutrient-dense foods and drinks. The move reflects how major food companies are adapting product lines to the rapid rise of anti-obesity medication use worldwide.

Lizzo's physical transformation is drawing widespread attention, with coverage focusing on how she achieved it through exercise, changes to her nutrition, and a new daily routine. The story frames her weight loss as the result of sustained lifestyle changes rather than a quick fix, and it is generating discussion about her health, body image, and public expectations of the singer.

A major clinical trial has found that diet drinks are just as effective as water for weight loss, challenging the common belief that artificially sweetened beverages undermine dieting efforts. Participants who consumed diet drinks lost weight comparably to those drinking water. Nutrition researchers say the findings could change guidance for people trying to cut calories while still enjoying sweet-tasting beverages.

Scientists behind GLP-1 weight-loss and diabetes drugs are among the favourites as Nobel Prize week begins, with bookmakers and commentators tipping the work for the medicine prize. The drugs' global impact on obesity treatment has fuelled expectations the researchers will be recognised when the awards are announced.

Rachael Ray, the American television cook and talk show host, is being discussed over noticeable changes in her appearance, with fans commenting on her weight loss across recent years. Coverage focuses on what Ray herself has said about her health and fitness approach, including her outlook on diet, exercise and lifestyle, rather than any single dramatic announcement from the celebrity chef.

Reba McEntire's name is being attached to a so-called morning weight loss trick involving baking soda and lemon water, driving a wave of searches about the drink and the country star's figure. There is no confirmation the singer uses or endorses the mixture, and health experts have long warned that baking soda drinks do not cause fat loss.

A new GLP-1 drug is under scrutiny as commentators ask whether it is a genuine medical advance or an overhyped product with unproven safety. GLP-1 medications, already widely used for diabetes and weight loss, have surged in popularity, and each new entrant prompts questions about side effects, long-term risks and who should take them. Coverage so far frames the drug as part of an ongoing debate rather than reporting confirmed safety problems.

Researchers report a clue that may help explain why people tend to regain weight after finishing a diet. The finding, covered by The Washington Post, points to biological mechanisms that could work against sustained weight loss, and is drawing attention for what it might mean for future obesity treatments.

Health experts are explaining why shedding pounds becomes more difficult after age 50, pointing to a slower metabolism, muscle loss and hormonal changes as key obstacles. Specialists recommend strength training, adequate protein intake and sustainable eating habits rather than crash diets to help older adults manage their weight effectively.

Weight-loss medications such as GLP-1 drugs are changing how gyms operate, as more members combine medication with training. The report examines how fitness businesses are adapting their programmes and services to a growing clientele using these drugs, and what the shift means for the industry's traditional focus on exercise alone as the path to losing weight.

News outlets are reporting on a new weight loss drug that has become associated with celebrity use. Coverage from international media highlights growing public interest in the medication, which follows a broader trend of high-profile figures turning to pharmaceutical treatments for rapid weight loss. The reports have fueled discussion about the drug's effectiveness, safety, and the ethics of celebrity endorsements in the booming weight loss market.

McDonald's is testing new high-protein menu items aimed at customers using weight-loss drugs such as Ozempic. The move reflects how appetite-suppressing medications are changing eating habits, with users seeking smaller portions and more protein. Restaurants are beginning to adapt their menus to this growing group of consumers, and McDonald's is among the first major fast-food chains to respond.

A recurring health question is making the rounds: whether eating a lot of protein damages the kidneys. Interest has been fuelled by the popularity of high-protein diets for weight loss and muscle building. Experts generally say healthy people tolerate higher protein intakes, but those with existing kidney disease are often advised to limit protein. Debate continues over long-term effects.

Questions are circulating about whether tennis champion Serena Williams is using weight loss drugs, after queries about her apparent transformation trended in news searches. The topic reflects broader public fascination with celebrity weight loss and the rise of medications like Ozempic. No confirmation has come from Williams herself, and any claims remain unverified speculation.

Commentators are speculating ahead of the 2026 Nobel Prize in Medicine, arguing the field has two leading contenders. One lane centers on GLP-1 weight-loss drugs such as Ozempic, which have transformed obesity treatment and become a major cultural and scientific phenomenon. The other leading area is unnamed in current discussion, but observers say both fields have strong cases for recognition when the prize is announced.

A Medium essay titled 'On Being Fat' by author J. Cafesin is circulating on social media, tagged across health, obesity, dieting and exercise topics. The piece addresses overweight, denial and the realities of weight loss, and is being shared amid ongoing holiday-season discussion about food, fitness and body health.